Publicaciones en las que colabora con Jesus M. Prieto Valtueña (8)

2013

  1. Prognostic factors and prevention of radioembolization-induced liver disease

    Hepatology, Vol. 57, Núm. 3, pp. 1078-1087

2011

  1. Adeno-associated virus liver transduction efficiency measured by in vivo [ 18F]FHBG positron emission tomography imaging in rodents and nonhuman primates

    Human Gene Therapy, Vol. 22, Núm. 8, pp. 999-1009

2010

  1. Analysis of prognostic factors after yttrium-90 radioembolization of advanced hepatocellular carcinoma

    International Journal of Radiation Oncology Biology Physics, Vol. 77, Núm. 5, pp. 1441-1448

2006

  1. Erratum: A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury (Cytokine (2003) 22 (12-20) DOI: 10.1016/S1043-4666(03)00101-7)

    Cytokine

2005

  1. Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8

    International Journal of Cancer, Vol. 116, Núm. 2, pp. 275-281

  2. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

    Gastroenterology, Vol. 128, Núm. 7, pp. 1787-1795

2004

  1. Positron emission tomography and gene therapy: Basic concepts and experimental approaches for in vivo gene expression imaging

    Molecular Imaging and Biology, Vol. 6, Núm. 4, pp. 225-238

2003

  1. A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

    Cytokine, Vol. 22, Núm. 1-2, pp. 12-20